Published in J Biol Chem on January 11, 2005
The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology (2010) 1.74
Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6. Exp Cell Res (2009) 1.15
Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility. J Cell Sci (2007) 0.91
Elevated soluble receptor activator of nuclear factor-kappaB ligand and reduced bone mineral density in patients with adolescent idiopathic scoliosis. Eur Spine J (2007) 0.89
Structure and elasticity of lipid membranes with genistein and daidzein bioflavinoids using X-ray scattering and MD simulations. J Phys Chem B (2012) 0.89
The role of microRNAs in osteoclasts and osteoporosis. RNA Biol (2014) 0.87
Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis. Eur Spine J (2009) 0.84
Genistein inhibits osteoclastic differentiation of RAW 264.7 cells via regulation of ROS production and scavenging. Int J Mol Sci (2014) 0.82
MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis. Int J Mol Sci (2016) 0.81
Effects of 6-Hydroxyflavone on Osteoblast Differentiation in MC3T3-E1 Cells. Evid Based Complement Alternat Med (2014) 0.79
Proteomic Analysis of Estrogen-Mediated Signal Transduction in Osteoclasts Formation. Biomed Res Int (2015) 0.75
Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells. J Cell Physiol (2009) 0.75
Glycitein decreases the generation of murine osteoclasts and increases apoptosis. Wien Med Wochenschr (2010) 0.75
Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro. Exp Ther Med (2017) 0.75
Adrenocorticotropic hormone and 1,25-dihydroxyvitamin D3 enhance human osteogenesis in vitro by synergistically accelerating the expression of bone-specific genes. Lab Invest (2017) 0.75
A new hominid from the Upper Miocene of Chad, Central Africa. Nature (2002) 6.85
FSH directly regulates bone mass. Cell (2006) 4.64
TSH is a negative regulator of skeletal remodeling. Cell (2003) 4.34
Macrovertebrate paleontology and the Pliocene habitat of Ardipithecus ramidus. Science (2009) 3.49
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med (2006) 3.14
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood (2014) 2.72
Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 2.66
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood (2010) 2.61
Geology and palaeontology of the Upper Miocene Toros-Menalla hominid locality, Chad. Nature (2002) 2.41
Asa Issie, Aramis and the origin of Australopithecus. Nature (2006) 2.00
Social evolution: kin preference in a social microbe. Nature (2006) 1.91
Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Invest (2012) 1.77
A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol (2007) 1.77
Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells (2005) 1.66
Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A (2006) 1.64
Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest (2003) 1.63
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci U S A (2010) 1.60
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol (2012) 1.58
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood (2011) 1.56
Na+/H+ exchanger regulatory factor 1 (NHERF1) directly regulates osteogenesis. J Biol Chem (2012) 1.52
The influence of age at single-event multilevel surgery on outcome in children with cerebral palsy who walk with flexed knee gait. Dev Med Child Neurol (2011) 1.40
Osteoclast signalling pathways. Biochem Biophys Res Commun (2005) 1.36
Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Mol Cell Biol (2005) 1.35
DNA damage drives accelerated bone aging via an NF-κB-dependent mechanism. J Bone Miner Res (2013) 1.31
The new framework for understanding placental mammal evolution. Bioessays (2009) 1.26
PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells. J Biol Chem (2007) 1.26
ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A (2010) 1.26
Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis. J Biol Chem (2010) 1.25
Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes. Hepatology (2010) 1.25
Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos (2004) 1.19
Towards a clinico-pathological classification of granule cell dispersion in human mesial temporal lobe epilepsies. Acta Neuropathol (2009) 1.17
G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses. Blood (2003) 1.17
Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci U S A (2005) 1.16
Loss of DNA polymerase zeta enhances spontaneous tumorigenesis. Cancer Res (2010) 1.15
Dental eruption in afrotherian mammals. BMC Biol (2008) 1.15
Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6. Exp Cell Res (2009) 1.15
Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration. Regen Med (2008) 1.14
TSH and bone loss. Ann N Y Acad Sci (2006) 1.12
FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochem Biophys Res Commun (2010) 1.12
Expression and function of TNF-family proteins and receptors in human osteoblasts. Bone (2003) 1.12
Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum (2010) 1.10
Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proc Natl Acad Sci U S A (2014) 1.10
Osteoclasts are important for bone angiogenesis. Blood (2009) 1.08
Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater (2008) 1.07
Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function. J Bone Miner Res (2006) 1.06
Tracking of human cells in mice. Histochem Cell Biol (2008) 1.06
Hepatocyte transplantation: clinical experience and potential for future use. Cell Transplant (2006) 1.05
Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development. Lab Invest (2012) 1.04
Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption. FASEB J (2003) 1.03
Calcium and bone disease. Biofactors (2011) 1.02
Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J Bone Miner Res (2003) 1.02
Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol (2007) 1.02
Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias. Clin Cancer Res (2010) 1.01
Thyroid-stimulating hormone, thyroid hormones, and bone loss. Curr Osteoporos Rep (2009) 1.00
Skeletal receptors for steroid-family regulating glycoprotein hormones: A multilevel, integrated physiological control system. Ann N Y Acad Sci (2011) 1.00
ACTH is a novel regulator of bone mass. Ann N Y Acad Sci (2010) 0.99
Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions. J Cell Physiol (2006) 0.97
NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. J Cell Sci (2005) 0.96
Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci U S A (2005) 0.96
Modulation of osteoblast gap junction connectivity by serum, TNFalpha, and TRAIL. Exp Cell Res (2007) 0.94
Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial. J Clin Pathol (2012) 0.93
Arabidopsis amidase 1, a member of the amidase signature family. FEBS J (2007) 0.93
Proresorptive actions of FSH and bone loss. Ann N Y Acad Sci (2007) 0.92
Comparison of fetal and adult marrow stromal cells in osteogenesis with and without glucocorticoids. Connect Tissue Res (2006) 0.92
CHDL: a cadherin-like domain in Proteobacteria and Cyanobacteria. FEMS Microbiol Lett (2005) 0.91
Blocking FSH action attenuates osteoclastogenesis. Biochem Biophys Res Commun (2012) 0.91
Subcellular localization and tissue specific expression of amidase 1 from Arabidopsis thaliana. Planta (2006) 0.91
Randomized crossover study to examine the necessity of an injection-to-meal interval in patients with type 2 diabetes and human insulin. Diabetes Care (2013) 0.91
Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility. J Cell Sci (2007) 0.91
In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. J Bone Miner Res (2004) 0.90
ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J Bone Miner Res (2011) 0.89
G-CSF stimulates Jak2-dependent Gab2 phosphorylation leading to Erk1/2 activation and cell proliferation. Cell Signal (2008) 0.89
CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists. J Med Chem (2005) 0.88
Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis. Biochem Biophys Res Commun (2005) 0.87
Special stem cells for bone. Cell Stem Cell (2012) 0.87
Osteopetrosis with micro-lacunar resorption because of defective integrin organization. Lab Invest (2009) 0.87
Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice. Cancer Biol Ther (2010) 0.87
A comparative study of four intensive care outcome prediction models in cardiac surgery patients. J Cardiothorac Surg (2011) 0.87
Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J Cell Biochem (2004) 0.87
Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore. Anal Biochem (2013) 0.86
Daily-Mean-SOFA, a new derivative to increase accuracy of mortality prediction in cardiac surgical intensive care units. Thorac Cardiovasc Surg (2012) 0.85
Vitamin C prevents hypogonadal bone loss. PLoS One (2012) 0.85
Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice. Int J Cancer (2012) 0.84
Pediatric myelodysplastic syndromes: they do exist! J Pediatr Hematol Oncol (2014) 0.84
Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection. Antimicrob Agents Chemother (2012) 0.84
NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts. Bone (2012) 0.84
High capacity Na+/H+ exchange activity in mineralizing osteoblasts. J Cell Physiol (2011) 0.84
Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas. J Nucl Med (2009) 0.83